Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001348362-24-000006
Filing Date
2024-12-03
Accepted
2024-12-03 14:03:28
Documents
1
Period of Report
2024-12-02

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 6106
  Complete submission text file 0001348362-24-000006.txt   7731
Mailing Address C/O LUCID, INC. 50 METHODIST HILL DR, SUITE 1000 ROCHESTER NY 14623
Business Address
CHRISTOPHER RICHARD (Reporting) CIK: 0001271244 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39874 | Film No.: 241522270

Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Issuer) CIK: 0001348362 (see all company filings)

EIN.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)